Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
British Journal of Clinical Pharmacology|January 15, 2026
Clozapine and norclozapine pharmacokinetic interaction with pantoprazoleOrwa Albitar, Sabariah Noor Harun, Siti Maisharah Sheikh Ghadzi
CNS Drugs|June 5, 2024
Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and GeneticsOrwa Albitar, Sabariah Noor Harun, Siti Maisharah Sheikh Ghadzi
Diabetes Research and Clinical Practice|July 6, 2020
Risk factors for mortality among COVID-19 patientsOrwa Albitar, Rama Ballouze, Jer Ping Ooi, et al.
Biomed Research International|January 31, 2020
Population Pharmacokinetics of Clozapine: A Systematic ReviewOrwa Albitar, Sabariah Noor Harun, Hadzliana Zainal, et al.
Pharmaceutics|August 28, 2021
A Repeated Time-to-Positive Symptoms Improvement among Malaysian Patients with Schizophrenia Spectrum Disorders Treated with ClozapineOrwa Albitar, Sabariah Noor Harun, Siti Nor Aizah Ahmad, et al.
Therapeutic Drug Monitoring|August 2, 2021
Time-Dissociated Pharmacokinetic Pharmacodynamic Model of Cyclosporine Among Malaysian Renal Transplant RecipientsOrwa Albitar, Sabariah Noor Harun, Rama Ballouze, et al.
Journal of Clinical Pharmacology|June 20, 2020
Population Pharmacokinetic Modeling of Cyclosporine Among Malaysian Renal Transplant Patients: An Evaluation of Methods to Handle Missing Doses in Conventional Drug-Monitoring DataOrwa Albitar, Rama Ballouze, Sabariah Noor Harun, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 15, 2022
Pharmacometric modeling of drug adverse effects: an application of mixture models in schizophrenia spectrum disorder patients treated with clozapineOrwa Albitar, Siti Maisharah Sheikh Ghadzi, Sabariah Noor Harun, et al.
The Journal of Antimicrobial Chemotherapy|April 25, 2024
Genetic and clinical predictors of rifapentine and isoniazid pharmacokinetics in paediatrics with tuberculosis infectionWeeraya Phaisal, Orwa Albitar, Pajaree Chariyavilaskul, et al.
Tuberculosis (Edinburgh, Scotland)|August 2, 2024
A time-to-event modelling of sputum conversion within two months after antituberculosis initiation among drug-susceptible smear positive pulmonary tuberculosis patients: Implementation of internal and external validationMohd Rahimi Muda, Orwa Albitar, Sabariah Noor Harun, et al.
Pageof 2